The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period. Introduction of advanced devices that aid in increasing efficiency of minimally invasive procedures and development of definition imaging devices such as 3D endoscope has provided a boost to the growth of the market.
Growing prevalence of gynecological diseases and conditions such as cervical cancer, uterine cancer, polycystic ovary syndrome, vaginal melanoma, extended bleeding, and irregular menstrual cycles are primarily resulting in increased demand for gynecological treatments. Moreover, rising awareness regarding benefits of regular check-ups is resulting in growth in the number of new cases of feminine diseases and conditions registered every year.
According to data published by the United Nations, the global female population accounted for more than 3.64 billion in 2015. Common reasons for visits to gynecologist include menstrual problems and pregnancy. Rising awareness and preventive check-ups to avoid late phase diagnosis of STDs are estimated to increase the number of these visits. This, in turn, will stir up the demand for gynecological devices.
Furthermore, soaring volume of surgical procedures such as ablation, laparoscopy, endoscopy, and female sterilization, coupled with growing usage of single-use products, is expected to bolster the demand for these products. Frequent introduction of technically advanced products is likely to spur the growth of the market over the forecast period.
However, stringent regulatory approval procedures to ensure safety of the products are restraining the growth of the market. Furthermore, rapidly developing alternative therapies such as personalized medicines and improved drug therapies are also poised to inhibit the growth of the market.
Based on product type, the market has been segmented into gynecological imaging devices, surgical devices, software, and handheld instruments. Surgical devices dominated the market with the largest share in 2018. High usage of endoscopy devices and female contraceptives is projected to support the dominance of the segment through 2025.
Need for highly durable and easily autoclavable surgical instruments has been increasing owing to growing number of surgical procedures across the globe. Advancements in technology and introduction of highly efficient devices that can provide quick and accurate diagnosis and minimize operating time are stimulating the growth of the global gynecological devices market.
Availability of various techniques pertaining to surgical instruments, such as hydrothermal, radiofrequency, and balloon ablation techniques, and development of devices used for multi purposes, such as modular forceps and scissor systems, are anticipated to contribute to the growth of the segment. Rising awareness regarding birth control devices and surgeries is also estimated to escalate the growth of the segment. Besides this, growing number of female sterilization procedures is also playing a vital role in the development of the market.
Growth in procedural volume of hysterectomy and laparoscopy is fostering the growth of the endoscope market. Furthermore, user-friendly designs of endoscopes are fueling their adoption since these products support minimally invasive procedures. Thus, endoscopy accounted for the largest share in the surgical devices segment in 2018.
North America dominated the global market in 2018. It is expected to maintain its dominance throughout the forecast period owing to availability of well-established healthcare infrastructure, high rate of awareness regarding availability of diagnostic tests and treatments, and rising reimbursement coverage.
Asia Pacific is likely to exhibit lucrative growth during the same period. China and India together account for the largest population base in the world. Thus, presence of large prospective patient pool is creating ample growth opportunities for gynecological device manufacturers. Government initiatives to control growing population in these countries through birth control programs are resulting in growth in awareness regarding contraceptive measures. China is among the countries having birth control policies.
Many countries such as Japan, Bangladesh, and Vietnam witness a high prevalence of sexually transmitted diseases in younger population, owing to lack of awareness and lack of easy access to contraceptive products. Rising prevalence of these diseases is poised to augment the market in Asia Pacific.
This industry is highly fragmented with presence of several local players. Therefore, industry players practice merger and acquisition strategies to sustain competition and increase market share. E.g., in November 2017, Cooper companies acquired Intra Uterine Device Para guard from Teva Pharmaceutical Industries Ltd for a sum of USD 1.1 billion. Some of the leading players operating in the global market are Medtronic plc; Cooper Surgical, Inc.; Richard Wolf GmbH.; Hologic, Inc.; Boston Scientific Corporation; Stryker Corporation; Karl Storz GmbH & Co. KG; and Ethicon, Inc.
Base year for estimation
Actual estimates/Historical data
2015 - 2017
2019 - 2026
Revenue in USD Million and CAGR from 2019 to 2026
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
U.S., Canada, U.K., Germany, Italy, France, Spain China, India, Japan, Thailand, New Zealand, South Korea, Mexico, Brazil, Argentina, Columbia, Saudi Arabia South Africa, U.A.E.
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global gynecological devices market report on the basis of product and region:
Product Outlook (Revenue, USD Million, 2014 - 2026)
Gynecological Endoscopy Devices
Endoscopic imaging systems
Endometrial Ablation Devices
Hydrothermal ablation devices
Radiofrequency ablation devices
Balloon ablation devices
Others (microwave, laser)
Fluid Management Systems
Female Sterilization/Contraceptive Devices
Permanent Birth Control
Intra Uterine Devices (IUD)
Subdermal Contraceptive Implants
Diagnostic Imaging Systems
Regional Outlook (Revenue, USD Million, 2014 - 2026)
Middle East & Africa
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.